MAPK8 and hepatocellular carcinoma: We found that NSC23766 inhibited CAMSAP2-mediated HCC invasion and metastasis by interrupting Rac1/JNK/c-Jun signaling; thus, it may serve as a novel therapeutic option for HCC.